ENTITY
Mezzion Pharma

Mezzion Pharma (140410 KS)

20
Analysis
Health Care • South Korea
Mezzion Pharma Co Ltd develops pharmaceutical products and out-licenses them to foreign countries including Canada, Mexico, Russia, and the United States. The Company's main products are for benign prostatic hyperplasia and erectile dysfunction.
more
bearish•Mezzion Pharma
•17 Mar 2026 15:52

KOSDAQ150 Index Adhoc Rebalance: Curiox Bio (445680 KQ) To Replace Mezzion Pharma (140410 KQ)

Mezzion Pharma has been added to the Investment Attention list and will be deleted from the KOSDAQ150 Index. Curiox Biosystems will be added to the...

Logo
494 Views
Share
bearish•Quantitative Analysis
•25 Mar 2026 07:05

KRX Short Interest Weekly (Mar 20th): Samsung F&M Insurance, SamsungElecMech, DWEC, Samsung SDI

We analyzed KRX short interest report for the past week and highlighted short interest changes in Samsung F&M Insurance, SamsungElecMech, DWEC,...

Logo
213 Views
Share
bearish•Quantitative Analysis
•23 Mar 2026 07:05

KRX Foreign Holding Weekly (Mar 20th): Samsung Electronics, Hyundai Motor, SK Hynix, KIA, ISUPETASYS

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, Hyundai Motor, SK Hynix,...

Logo
304 Views
Share
•04 Nov 2019 08:45

Stock Short Ideas Within an Index Long Environment

Positioning is quickly shifting to more index net longs and we are on the hunt for stock shorts in Asia given the more bullish Q4 seasonality and...

Share
•26 Aug 2018 23:31

EM Strategy: Remain Overweight India

In this report we provide a synopsis of EM markets. We also scour the EM universe for attractive and actionable opportunities, highlighting...

Logo
576 Views
Share
x